SEC Form 4 · accession 0000904454-17-000527
Paratek Pharmaceuticals, Inc. · PRTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Bigham
Officer — Chairman and CEO · Director
Period of report
Jul 19, 2017
Accepted (ET)
Jul 21, 2017 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178711
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 19, 2017 | M | 23,255 | $4.30 | A | 127,680 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F3,F4 | $4.30 | Jul 19, 2017 | M | 23,255 | D | — | Jun 28, 2024 | Common Stock | 23,255 | 121,838 | D |
Explanation of responses
- F1Shares of common stock acquired from the exercise of a stock option.
- F2The Issuer entered into an Agreement and Plan of Merger and Reorganization, dated as of June 30, 2014 (the "Merger Agreement"), by and among the Issuer, Tigris Merger Sub, Inc., Tigris Acquisition Sub, LLC and a Delaware corporation then known as Paratek Pharmaceuticals, Inc. ("Old Paratek").
- F3On June 29, 2014, the Reporting Person was granted an option to purchase 2,149,529 shares of the common stock of Old Paratek under Old Paratek's 2014 Equity Incentive Plan at a per share exercise of price of $0.29 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 145,093 shares of the Issuer's common stock at a per share exercise price of $4.30 upon closing of the merger. The option was previously reported on Form 4 filed on November 3, 2014.
- F4This stock option originally vested monthly over four years measured from the vesting commencement date of January 1, 2015, subject generally to the Reporting Person's continued employment with the Issuer. On October 9, 2015, this stock option was amended to conform the award's vesting schedule to other new hire grants. Following the amendment, 25% of the award would vest on January 1, 2016 with the remaining 75% of the award to vest in a series of thirty-six successive equal monthly installments measured from January 1, 2016, subject generally to the Reporting Person's continued employment with the Issuer.